VEGFA and neoplasm: However, subsequent research revealed a more complex effect, showing that anti-VEGFA therapy can also transiently normalize tumor vasculature, improving perfusion through reduced vascular density, increased blood flow, decreased permeability, and enhanced pericyte recruitment (151).